Citrine Global Corp. announced that its subsidiary, Cannovation Center Israel Ltd. has filed in the U.S. Patent & Trademark Office a provisional patent application for "PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF SIDE EFFECTS ASSOCIATED WITH THE USE OF CANNABIS, CANNABINOIDS, AND RELATED PRODUCTS". The invention addresses technologies and solutions to support medical cannabis patients who experience side effects related to their cannabis treatment.